» Articles » PMID: 20364121

Conversion of Adult Pancreatic Alpha-cells to Beta-cells After Extreme Beta-cell Loss

Overview
Journal Nature
Specialty Science
Date 2010 Apr 6
PMID 20364121
Citations 602
Authors
Affiliations
Soon will be listed here.
Abstract

Pancreatic insulin-producing beta-cells have a long lifespan, such that in healthy conditions they replicate little during a lifetime. Nevertheless, they show increased self-duplication after increased metabolic demand or after injury (that is, beta-cell loss). It is not known whether adult mammals can differentiate (regenerate) new beta-cells after extreme, total beta-cell loss, as in diabetes. This would indicate differentiation from precursors or another heterologous (non-beta-cell) source. Here we show beta-cell regeneration in a transgenic model of diphtheria-toxin-induced acute selective near-total beta-cell ablation. If given insulin, the mice survived and showed beta-cell mass augmentation with time. Lineage-tracing to label the glucagon-producing alpha-cells before beta-cell ablation tracked large fractions of regenerated beta-cells as deriving from alpha-cells, revealing a previously disregarded degree of pancreatic cell plasticity. Such inter-endocrine spontaneous adult cell conversion could be harnessed towards methods of producing beta-cells for diabetes therapies, either in differentiation settings in vitro or in induced regeneration.

Citing Articles

Transdifferentiation of plasmatocytes to crystal cells in the lymph gland of Drosophila melanogaster.

Marcetteau J, Duarte P, Leitao A, Sucena E EMBO Rep. 2025; .

PMID: 40075235 DOI: 10.1038/s44319-025-00366-z.


Pancreatic Ductal Cell Heterogeneity: Insights into the Potential for β-Cell Regeneration in Diabetes.

Britt M, Abdilmasih N, Rezanejad H Stem Cell Rev Rep. 2025; .

PMID: 40063303 DOI: 10.1007/s12015-025-10859-y.


Identification of mouse and human embryonic pancreatic cells with adult Procr progenitor transcriptomic and epigenomic characteristics.

Heidenreich A, Bacigalupo L, Rossotti M, Rodriguez-Segui S Front Endocrinol (Lausanne). 2025; 16:1543960.

PMID: 40017694 PMC: 11864936. DOI: 10.3389/fendo.2025.1543960.


Recent advances in pancreatic α-cell transdifferentiation for diabetes therapy.

Li Y, Zhu J, Yue C, Song S, Tian L, Wang Y Front Immunol. 2025; 16:1551372.

PMID: 39911402 PMC: 11794509. DOI: 10.3389/fimmu.2025.1551372.


Mechanistic insights and approaches for beta cell regeneration.

Karampelias C, Liu K, Tengholm A, Andersson O Nat Chem Biol. 2025; .

PMID: 39881214 DOI: 10.1038/s41589-024-01822-y.


References
1.
Bonner-Weir S, Weir G . New sources of pancreatic beta-cells. Nat Biotechnol. 2005; 23(7):857-61. DOI: 10.1038/nbt1115. View

2.
Wang Z, Mu J, Schraw T, Gautron L, Elmquist J, Zhang B . PANIC-ATTAC: a mouse model for inducible and reversible beta-cell ablation. Diabetes. 2008; 57(8):2137-48. PMC: 2494693. DOI: 10.2337/db07-1631. View

3.
Chakrabarti S, James J, Mirmira R . Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding. J Biol Chem. 2002; 277(15):13286-93. DOI: 10.1074/jbc.M111857200. View

4.
Ritz-Laser B, Gauthier B, Estreicher A, Mamin A, Brun T, Ris F . Ectopic expression of the beta-cell specific transcription factor Pdx1 inhibits glucagon gene transcription. Diabetologia. 2003; 46(6):810-21. DOI: 10.1007/s00125-003-1115-7. View

5.
Karges B, Durinovic-Bello I, Heinze E, Debatin K, Boehm B, Karges W . Immunological mechanisms associated with long-term remission of human type 1 diabetes. Diabetes Metab Res Rev. 2005; 22(3):184-9. DOI: 10.1002/dmrr.600. View